Descriptive analysis of treatment outcomes and the year of treatment started in all eligible patients (N = 4029). Table S2. Type of standardized regimens of included patients. Table S3. Resistance pattern of patients included in the study (n = 1972). Table S4. The association of use of individual drugs and treatment outcomes (DOCX 108 kb
Table S1. a. Outcome by treatment within gender and HIV subgroups. b. Outcome by treatment within ge...
Table S1. Profile study population with and without tuberculosis treatment outcome registration, São...
Supplementary material response to ART in HIV-TB. Figure S1. Probability of death in efavirenz and n...
Characteristics of MDR-TB patients who have completed treatment, by treatment duration, a two-by-two...
Treatment duration in days of MDR-TB patients who have completed treatment, a table showing the trea...
Summary of epidemiological data, economic profile, and MDR-TB interventions in high burden countries...
Table S2. The quality assessment of the included studies into the present meta-analysis (DOCX 14 kb
Table S1. Descriptive statistics of the current studied patients and the patients who were not studi...
PRISMA checklist. Table S2: Search terms applied in PubMed. Table S3: Number of search hits by data...
Table S1. Sequencing statistics of the 18Â M. tuberculosis isolates. Note: A, B, C, and D indicate t...
Different assumptions concerning progression rate and sensitivity as well as specificity of the TST ...
Summary of definitions used in the study. Tables detailing: immunosuppressive medication received by...
Table S1 Clinical and Laboratory Characteristics of the Patients. Table S2 Agreement between three r...
Supplementary text, figures and tables. In this document we elaborate on the efficacy of treatment (...
Reported long-term TB incidence rates in IPT trials. Figure S1. Thibela TB study schematic of enrolm...
Table S1. a. Outcome by treatment within gender and HIV subgroups. b. Outcome by treatment within ge...
Table S1. Profile study population with and without tuberculosis treatment outcome registration, São...
Supplementary material response to ART in HIV-TB. Figure S1. Probability of death in efavirenz and n...
Characteristics of MDR-TB patients who have completed treatment, by treatment duration, a two-by-two...
Treatment duration in days of MDR-TB patients who have completed treatment, a table showing the trea...
Summary of epidemiological data, economic profile, and MDR-TB interventions in high burden countries...
Table S2. The quality assessment of the included studies into the present meta-analysis (DOCX 14 kb
Table S1. Descriptive statistics of the current studied patients and the patients who were not studi...
PRISMA checklist. Table S2: Search terms applied in PubMed. Table S3: Number of search hits by data...
Table S1. Sequencing statistics of the 18Â M. tuberculosis isolates. Note: A, B, C, and D indicate t...
Different assumptions concerning progression rate and sensitivity as well as specificity of the TST ...
Summary of definitions used in the study. Tables detailing: immunosuppressive medication received by...
Table S1 Clinical and Laboratory Characteristics of the Patients. Table S2 Agreement between three r...
Supplementary text, figures and tables. In this document we elaborate on the efficacy of treatment (...
Reported long-term TB incidence rates in IPT trials. Figure S1. Thibela TB study schematic of enrolm...
Table S1. a. Outcome by treatment within gender and HIV subgroups. b. Outcome by treatment within ge...
Table S1. Profile study population with and without tuberculosis treatment outcome registration, São...
Supplementary material response to ART in HIV-TB. Figure S1. Probability of death in efavirenz and n...